✦ LIBER ✦

Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b interferon

✍ Scribed by J. A. Cabrera Gómez; J. R. Cordero Gutierrez; O. Fernández López; B. Reyes Gutiérrez; K. Romero Garcia; J. Simón Consuegra; R. Feas Cruz; A. González Quevedo; I. Alfaro Capdegille; M. Del Pino Falcón; S. Williams Serrano; M. Vega Galindo; P. López Saura; Y. Bello Rivero

Publisher: Springer
Year: 1993
Tongue: English
Weight: 784 KB
Volume: 7
Category: Article
ISSN: 0921-299X
DOI: 10.1007/bf01878151

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with natural human interferon

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b

✍ Freund, M. ;Wussow, P. ;Kn�ver-Hopf, J. ;Mohr, H. ;Pohl, U. ;Exeriede, G. ;Link, 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 437 KB

Pharmacokinetics and tolerance of intrav

Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2 interferon in patients with malignancies

✍ I. Shah; J. Band; M. Samson; J. Young; R. Robinson; B. Bailey; A. Martin Lerner; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

Treatment of thrombocytosis in myeloprol

Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a

✍ Tichelli, A. ;Gratwohl, A. ;Berger, C. ;Lori, A. ;W�rsch, A. ;Dieterle, A. ;Thom 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 449 KB

Treatment of chronic myelogenous leukemi

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b

✍ Norbert Niederle; Otto Kloke; Dieter May; Reinhard Becher; Rainhardt Osieka; Car 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 422 KB

Treatment of metastatic malignant melano

Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b

✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis

Treatment of acute non-A, non-B hepatiti

Treatment of acute non-A, non-B hepatitis with interferon alpha-2b

✍ N. C. Tassopoulos; Maria Koutelou; G. Papatheodoridis; Th. Giannikakis; Melpomen 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 192 KB